When did Organon report Q4 2025 earnings?

Organon (OGN) reported Q4 2025 earnings on February 12, 2026 before market open.

What were Organon's Q4 2025 revenue and EPS?

Organon reported revenue of $1.5B and eps of $0.63 for Q4 2025.

Did Organon beat estimates in Q4 2025?

Revenue missed the consensus estimate of $1.5B by $27.8M. EPS missed the consensus estimate of $0.73 by $0.10.

How did Organon's Q4 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 5.3% from $1.6B a year earlier and eps declined 30.0% from $0.90.

Where can I find Organon's Q4 2025 SEC filings?

You can read the 8-K earnings release (0001104659-26-013888) and the 10-K periodic report (0001628280-26-011125) directly on SEC EDGAR. The filing index links above go to sec.gov.

Organon OGN Q4 2025 Annual earnings

Reported February 12, 2026 · Before market open

Revenue$1.5BMiss by $27.8M

EPS$0.63Miss by $0.10

Revenue estimate$1.5B

EPS estimate$0.73

Next report

Aug 4, 2026 (In 6 days)

Revenue estimate$1.6B

EPS estimate$0.87

Financials

Q4 2025

Income statement

See full

Revenue$1.5B-5.3%

Gross profit$741.0M-17.3%

Balance sheet

See full

Cash & equivalents$574.0M-15.0%

Total debt$8.8B-2.6%

Total equity$752.0M+59.3%

Total assets$12.9B-1.8%

Cash flow

See full

Operating cash flow$141.0M-63.8%

CapEx$45.0M-18.2%

Free cash flow$96.0M-71.3%

Valuation & ratios

Valuation

as of 12/31/25

See full

Market cap$1.86B-51.5%

Enterprise value$10.09B-17.3%

P/S0.3×-0.3×

Profitability

See full

Gross margin53.3%-4.7pp

FCF margin8.7%-3.3pp

Returns & leverage

See full

Debt / equity11.7×-7.4×

Current ratio1.8×+0.2×

Segments

By product

See full

Nexplanon/Implanon NXT$210.0M-18.9%

Zetia$90.0M+16.9%

Other$85.0M-2.3%

Other Non-Opiod Pain, Bone and Dermatology$72.0M—

Arcoxia$70.0M+18.6%

By geography

See full

Europe and Canada$406.0M-3.3%

Latin America, Middle East, Russia, and Africa$262.0M-1.5%

Asia Pacific and Japan$248.0M+1.6%

Other$17.0M-48.5%

Versus estimates

Revenue

Q1 2026$1.5BMiss by $27.5M

Q4 2025$1.5BMiss by $27.8M

Q3 2025$1.6BBeat by $80.0M Q2 2025$1.6BBeat by $32.4M Q1 2025$1.5BMiss by $23.3M Q4 2024$1.6BIn line

Diluted EPS

Q1 2026$0.71Miss by $0.12

Q4 2025$0.63Miss by $0.10

Q3 2025$1.01Beat by $0.08 Q2 2025$1.00Beat by $0.06 Q1 2025$1.02Beat by $0.13 Q4 2024$0.90Miss by $0.02

Ask the moment Organon reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Organon report Q4 2025 earnings?: Organon (OGN) reported Q4 2025 earnings on February 12, 2026 before market open.
What were Organon's Q4 2025 revenue and EPS?: Organon reported revenue of $1.5B and eps of $0.63 for Q4 2025.
Did Organon beat estimates in Q4 2025?: Revenue missed the consensus estimate of $1.5B by $27.8M. EPS missed the consensus estimate of $0.73 by $0.10.
How did Organon's Q4 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue declined 5.3% from $1.6B a year earlier and eps declined 30.0% from $0.90.
Where can I find Organon's Q4 2025 SEC filings?: You can read the 8-K earnings release (0001104659-26-013888) and the 10-K periodic report (0001628280-26-011125) directly on SEC EDGAR. The filing index links above go to sec.gov.